Cargando…
Challenge models to assess new therapies in chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality. Current therapies confer partial benefits either by incompletely improving airflow limitation or by reducing acute exacerbations, hence new therapies are desirable. In the absence of robust early predictors of...
Autores principales: | van der Merwe, René, Molfino, Nestor A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459659/ https://www.ncbi.nlm.nih.gov/pubmed/23055710 http://dx.doi.org/10.2147/COPD.S30664 |
Ejemplares similares
-
Gene-environment interactions in chronic obstructive pulmonary disease
por: Molfino, Nestor A, et al.
Publicado: (2008) -
Pulmonary nocardiosis in Chronic Obstructive Pulmonary Disease: A new clinical challenge
por: Castellana, Giorgio, et al.
Publicado: (2016) -
Challenges in Diagnosing Occupational Chronic Obstructive Pulmonary Disease
por: Libu, Cristiana, et al.
Publicado: (2021) -
Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management
por: Roca, Josep, et al.
Publicado: (2014) -
Respiratory dialysis: a new therapy for chronic obstructive pulmonary disease
por: Morley, S, et al.
Publicado: (2008)